Merck (MRK) Change in Acquisitions & Divestments (2009 - 2025)

Merck (MRK) reported Change in Acquisitions & Divestments of $46.0 million for Q4 2025, up 112.43% year-over-year from $21.7 million in Q4 2024, and down 92.0% quarter-over-quarter from $575.0 million in Q3 2025.

Merck (MRK) Change in Acquisitions & Divestments (2009 - 2025) Analysis & Trends

Merck (MRK) has 17 years of Change in Acquisitions & Divestments data on file, last reported at $46.0 million in Q4 2025.

  • Change in Acquisitions & Divestments for Q4 2025 came in at $46.0 million, up 112.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 523.47% YoY), and the FY2025 annual result was $1.7 billion, changed N/A from the prior year.
  • Change in Acquisitions & Divestments fell to $46.0 million in Q4 2025 per MRK's latest filing, from $575.0 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $704.0 million in Q3 2023 and troughed at -$370.0 million in Q4 2024.
  • A 5-year average of $267.5 million and a median of $285.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments jumped 49900.0% in 2023, then sank 318.93% in 2024.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $529.0 million in 2021, then plunged by 97.73% to $12.0 million in 2022, then surged by 1308.33% to $169.0 million in 2023, then slumped by 318.93% to -$370.0 million in 2024, then surged by 112.43% to $46.0 million in 2025.
  • Business Quant data shows MRK's Change in Acquisitions & Divestments at $46.0 million in Q4 2025, $575.0 million in Q3 2025, and $601.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 46.00 Mn
Dec 31, 2025 46.00 Mn
Sep 30, 2025 575.00 Mn
Sep 30, 2025 575.00 Mn
Jun 30, 2025 601.00 Mn
Jun 30, 2025 601.00 Mn
Mar 31, 2025 456.00 Mn
Mar 31, 2025 456.00 Mn
Dec 31, 2024 -370.00 Mn
Dec 31, 2024 -370.00 Mn
Sep 30, 2024 50.00 Mn
Sep 30, 2024 50.00 Mn
Jun 30, 2024 60.00 Mn
Jun 30, 2024 60.00 Mn
Mar 31, 2024 260.00 Mn
Mar 31, 2024 260.00 Mn
Dec 31, 2023 169.00 Mn
Dec 31, 2023 169.00 Mn
Sep 30, 2023 704.00 Mn
Sep 30, 2023 704.00 Mn